Rutgers, New Jersey Medical School is a clinical research site located in Newark, New Jersey, United States 07103.
Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.
Rutgers, New Jersey Medical School has participated in 2 clinical trials.
Therapeutic areas: Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Non Arteritic Anterior Ischemic Optic Neuropathy.
Sponsors: Genfit, Quark Pharmaceuticals.
Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rutgers, New Jersey Medical School has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rutgers, New Jersey Medical School has 2 clinical trials on record. Their work covers Nonalcoholic Steatohepatitis (NASH) With Fibrosis, Non Arteritic Anterior Ischemic Optic Neuropathy.
Rutgers, New Jersey Medical School has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.